| Financial Year |
March 31 2023 |
| Monetary Funds |
1,162,103,780.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
66,668,540.41 |
| Accounts Receivable |
1,911,977,833.21 |
| Advances to Suppliers |
34,406,191.48 |
| Other Receivables |
47,445,190.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
852,799,172.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,826,165.48 |
| Total Current Assets |
4,410,638,873.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
405,409,144.55 |
| Long-term Equity Investment |
2,161,110.49 |
| Investment Properties |
3,370,233.40 |
| Fixed Assetes |
2,109,710,580.61 |
| Under-construction Projects |
449,036,210.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
850,755,586.62 |
| R&D expenses |
163,931,206.76 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,624,757.06 |
| Deferred Income Tax Assets |
38,674,514.67 |
| Other Non-Current Assets |
12,342,625.60 |
| Sub-Total of Non-Current Assets |
4,090,046,068.51 |
| Total Assets |
8,500,684,941.77 |
| Short-Term Loans |
3,095,322,332.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
938,202,303.48 |
| Accounts Payable |
1,862,795,213.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,365,223.39 |
| Taxes Payable |
17,722,961.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
286,226,602.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
417,013,974.22 |
| Other Current Liabilities |
48,125,108.75 |
| Sub-Total of Current Liabilities |
6,816,276,600.68 |
| Long-term Loans |
1,378,549,883.68 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
14,120,526.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,418,108.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,498,758,630.38 |
| Total Liabilities |
8,315,035,231.06 |
| Paid-In Capital(Or Share Stock) |
654,314,844.00 |
| Capital Surplus |
3,158,061,421.77 |
| Surplus Reserve |
102,266,819.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,802,310,179.44 |
| Minority Stockholder's Interest |
59,281,822.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
126,367,888.37 |
| Owner's Equity（Stockholder's Equity） |
185,649,710.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,500,684,941.77 |
